Long-term effect of liver transplantation on cirrhotic autonomic cardiac dysfunction

Luigi Baratta1, Luigi Tubani, Manuela Merli

  • 1Department of Medicina Clinica Sapienza University, Rome, Italy.

Insights

Liver transplantation partially improves cardiac autonomic function in cirrhotic patients, specifically heart rate variability (HRV) measured by SDNN. However, parasympathetic function remains impaired long-term post-transplant.

Area of Science:

  • Cardiology
  • Hepatology
  • Autonomic Neuroscience

Background:

  • Cirrhosis is associated with cardiac autonomic dysfunction.
  • Long-term effects of liver transplantation (LT) on cardiac autonomic function are not well understood.

Purpose of the Study:

  • To compare cardiac autonomic function before and long-term after LT in cirrhotic patients.
  • To assess the impact of LT on heart rate variability (HRV) parameters.

Main Methods:

  • Cross-sectional and prospective study design.
  • Involved 30 cirrhotic patients awaiting LT, 15 patients 2-6 years post-LT, and 27 healthy controls.
  • Cardiac autonomic function assessed using 24-hour electrocardiogram (ECG) and heart rate variability (HRV) analysis.

Main Results:

  • Cirrhotic patients exhibited reduced HRV (SDNN, RMS-SD) and increased sympathetic activity (LF/HF ratio at night) compared to controls.
  • LT patients showed improved SDNN compared to pre-transplant cirrhotics, but RMS-SD and LF/HF at night remained unchanged.
  • Prospective analysis revealed a progressive increase in SDNN post-LT, significantly higher at 12 and 33 months.

Conclusions:

  • Liver transplantation partially corrects the overall decrease in HRV (SDNN) in cirrhotic patients.
  • Parasympathetic dysfunction, indicated by RMS-SD and LF/HF at night, persists long-term after LT.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...